Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Docusate calcium is an anionic surfactant that serves as a stool softener for the management of constipation. Its primary mechanism involves lowering the surface tension of the fecal mass, which promotes the incorporation of water and lipids into the stool, thereby softening it and facilitating easier evacuation without directly stimulating peristalsis. It is frequently indicated for patients who need to avoid straining during defecation, such as those recovering from abdominal surgery or a myocardial infarction. While effective for softening stool, it is generally considered a mild laxative and is often used for maintenance or in combination with stimulant laxatives for more comprehensive bowel management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on docusate calcium.